Company Filing History:
Years Active: 2012
Title: Innovations by AlSayed AlArabi Sallam: A Focus on Pharmaceutical Advancements
Introduction: AlSayed AlArabi Sallam, based in Amman, Jordan, is a notable inventor in the pharmaceutical field. He has made significant contributions through his work, particularly in the development of a unique formulation and process that enhances the therapeutic potential of modafinil.
Latest Patents: AlSayed holds a patent for a formulation and process for the preparation of modafinil. This invention specifically includes pharmaceutical tablets that comprise modafinil particles and utilize one or more pharmaceutically acceptable excipients. Notably, the modafinil particles in his formulation have a size distribution such that at least about 65% have a diameter greater than 220 microns, ensuring bioequivalence to PROVIGIL®. The method of preparation employed is a dry granulation technique, showcasing innovative approaches in pharmaceutical manufacturing.
Career Highlights: AlSayed AlArabi Sallam currently works at Hikma Pharmaceuticals LLC, an established company in the pharmaceutical industry. His role at Hikma has allowed him to further his research and development efforts, leading to impactful inventions that contribute to improved patient care and treatment options.
Collaborations: Throughout his career, AlSayed has collaborated with talented colleagues such as Mohannad Shawer and Dalia Jawhari. These collaborations highlight the importance of teamwork in driving innovation and the sharing of knowledge within the pharmaceutical sector.
Conclusion: AlSayed AlArabi Sallam's dedication to advancing pharmaceutical formulations demonstrates the crucial role inventors play in the industry. With his patent on modafinil, he not only provides new treatment avenues for various diseases but also reinforces the ongoing quest for medical innovations that benefit patients worldwide.